Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial

Conclusions. Oral fluconazole at a dosage of 6.5–8 mg/kg/d for 28 days should not be considered an effective treatment for CL caused by L. braziliensis.
Clinical Trials Registration. NCT01953744.

Source: Clinical Infectious Diseases - December 15, 2016 Category: Infectious Diseases Authors: Prates, F. V. d. O., Dourado, M. E. F., Silva, S. C., Schriefer, A., Guimaraes, L. H., Brito, M. d. G. O., Almeida, J., Carvalho, E. M., Machado, P. R. L. Tags: ARTICLES AND COMMENTARIES Source Type: research